A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis.

NONMEM WHO ethionamide isoniazid paediatric dosing pyrazinamide rifampicin rifampin

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2023
Historique:
received: 27 09 2022
accepted: 01 03 2023
pubmed: 14 5 2023
medline: 14 5 2023
entrez: 14 5 2023
Statut: epublish

Résumé

Following infection with

Identifiants

pubmed: 37180707
doi: 10.3389/fphar.2023.1055329
pii: 1055329
pmc: PMC10167634
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1055329

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © World Health Organization 2023. Licensee Frontiers Media SA.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Roeland E Wasmann (RE)

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Tiziana Masini (T)

World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland.

Kerri Viney (K)

World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland.

Sabine Verkuijl (S)

World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland.

Annemieke Brands (A)

World Health Organization, Global Tuberculosis Programme, Geneva, Switzerland.

Anneke C Hesseling (AC)

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Helen McIlleron (H)

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Paolo Denti (P)

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Kelly E Dooley (KE)

Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN, United States.

Classifications MeSH